Caricamento...
ANXIOSELECTIVE ANXIOLYTICS: ON A QUEST FOR THE HOLY GRAIL
The discovery of “benzodiazepine receptors” provided the impetus to discover and develop anxioselective anxiolytics (“Valium(®) without the side effects”). The market potential for a GABA(A) receptor-based anxioselective resulted in multiple compounds entering clinical trials. In contrast to the anx...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3482271/ https://ncbi.nlm.nih.gov/pubmed/22981367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2012.08.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|